News

Find News

Filter articles

Applied Filters

Showing 641 to 650 of 697 results

Horizon boosts portfolio with Vidara merger

Ireland, US20-03-2014Mergers & acquisitions

Horizon Pharma is set to acquire Dublin-based Vidara Therapeutics in a merger worth about $660 million, the companies announced on March 19.

Idenix brings Gilead patent battle to Europe

France, Germany, UK17-03-2014Legal developments

Massachusetts-based Idenix Pharmaceuticals has filed patent infringement cases against Gilead Sciences and its European subsidiaries in France, Germany and the UK.

“Patent cliff” blamed for contraction in Irish economy

Ireland14-03-2014

A contraction of 0.3 percent in Ireland’s economy last year has been linked to the expiry of several key pharmaceutical patents.

Update to UPC rules clarifies “opt-out” scheme

11-03-2014

The Unified Patent Court has clarified its opt-out scheme, making clear that when a European patent has been opted out of the scheme, its associated supplementary protection certificate will follow.

Life Sciences Law Forum: UPC: “So much more to be done”

EU05-03-2014

While the political will exists for the introduction of the Unified Patent Court next year, much more still needs to be done, according to Adam Cooke, a partner in DLA Piper's IP and technology group.

Life Sciences Law Forum: disclosure of clinical data a key concern

International04-03-2014

A key concern for lawyers and in-house counsels practising in the pharmaceutical industry is the disclosure of clinical data, according to the co-chairs of DLA Piper's Global Life Sciences sector, Bonella Ramsay and John Dougherty.

Bayer to buy traditional Chinese medicine group

China, Germany27-02-2014

Bayer has announced that it plans to acquire Dihon Pharmaceutical Group, a Chinese company that makes over-the-counter (OTC) and herbal traditional Chinese medicine (TCM) products.

Bayer set to complete Algeta acquisition

Germany, Norway, US24-02-2014Mergers & acquisitions

Bayer will acquire Norwegian pharmaceutical company Algeta for €2.1 billion ($2.9 million), it announced on Monday.

Actavis to buy Forest for $25 billion

Ireland, US21-02-2014Mergers & acquisitions

Actavis has announced another expansion with the $25 billion acquisition of US pharmaceutical company Forest Laboratories.

Baker & McKenzie adds to IP team

UK17-02-2014

Baker & McKenzie LLP has added to its IP team with the appointment of Hiroshi Sheraton as partner in its London office.

Showing 641 to 650 of 697 results

LSIPR